IP Library Granted Patent US 10,136,845
Granted Patent B2
US 10,136,845 · App. 14/214,430 · Granted Nov 27, 2018

Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same

Inventors: Marc Barry Taub (Mountain View, CA); Jai Karan (Hyderabad, IN); Annie C. Tan (Redwood City, CA); Timothy Christian Dunn (San Francisco, CA); Joel Goldsmith (Oakland, CA); Christine M. Neuhaus (San Jose, CA); Stephen A. Rossi (Clayton, CA); Sujit R. Jangam (Castro Valley, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61B5/1473A61B5/14532G01N33/48792A61B5/0004A61B5/6833A61B5/6847A61B5/744A61B5/7435A61B2560/0209A61B2560/0252
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,136,845
App. No.
14/214,430
Granted
Nov 27, 2018
Kind
B2
Abstract

Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.

Claims (22)

1. An apparatus for receiving analyte data from an in vivo analyte sensing device, comprising:

a housing;

a display mounted on the housing;

an input component;

a test strip port;

a processor mounted in the housing; and

a memory storing instructions which, when executed by the processor, cause the processor to:

navigate from a current user interface screen on the display to a home screen in response to a press of the input component by a user unless a test strip is in the test strip port and a test strip result has not yet been computed;

cause display of the home screen, wherein the home screen includes an indication of the time remaining until the in vivo analyte sensing device expires; and

cause display of received analyte information,

wherein the instructions, when executed by the processor, cause the processor to render inactive the press of the input component by the user to navigate from the current user interface screen on the display to the home screen if the test strip is in the test strip port and the test strip result has not yet been computed.

2. The apparatus of claim 1 , wherein the home screen includes an indication of an estimated insulin-on-board amount.

3. The apparatus of claim 2 , wherein the indication of the estimated insulin-on-board amount includes a person-shaped icon, wherein the estimated insulin-on-board amount is represented by a fill percentage of the person-shaped icon.

4. The apparatus of claim 1 , wherein the display of analyte information includes a numerical current analyte level, a graphical representation of past analyte levels, and an arrow representing a trend of the numerical current analyte level.

5. The apparatus of claim 4 , wherein the graphical representation of past analyte levels includes 8 hours of past analyte data.

6. The apparatus of claim 1 , wherein navigation from the current user interface screen to the home screen includes performance of a check whether the in vivo analyte sensing device is expired and, if the in vivo analyte sensing device is expired, then causation of display of a sensor expired notification.

7. The apparatus of claim 6 , wherein the sensor expired notification requires confirmation to permit navigation to the home screen.

8. The apparatus of claim 6 , wherein the instructions, when executed by the processor, further cause the processor to calculate, if the check indicates the in vivo analyte sensing device is not expired, a time remaining until the in vivo analyte sensing device expires prior to display of the indication of the time remaining until the in vivo analyte sensing device expires.

9. The apparatus of claim 8 , wherein the indication of the time remaining before expiration of the in vivo analyte sensing device includes an indication of no active sensor, and the time remaining is displayed as a number of days when the time remaining is greater than 1 day, as a number of hours when the time remaining is greater than 1 hour and less than 1 day, and as a number of minutes when the time remaining is less than 1 hour.

10. The apparatus of claim 1 , wherein the input component is integrated with the display.

11. The apparatus of claim 1 , wherein the press of the input component is a first press for a first duration, and wherein the apparatus is configured to power off in response to a second press of the input component by the user for a second duration that is relatively longer than the first duration.

12. The apparatus of claim 1 , further comprising a radio frequency (RF) front end, wherein the apparatus is adapted to turn the RF front end from an on state to an off state when the test strip is inserted in the test strip port.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: TAUB, MARC BARRY; KARAN, JAI; TAN, ANNIE C.; DUNN, TIMOTHY CHRISTIAN; GOLDSMITH, JOEL; NEUHAUS, CHRISTINE M.; ROSSI, STEPHEN A.; JANGAM, SUJIT R.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 033182/0294 →
Continuity (6)
Continuation In Part 13407617 · Feb 28, 2012
Provisional Application 61492266 · Jun 1, 2011
Provisional Application 61489098 · May 23, 2011
Provisional Application 61447645 · Feb 28, 2011
Provisional Application 61801518 · Mar 15, 2013
Related Publication 20140200426A1 · Jul 17, 2014
Cited By (15)
US 1,070,887 US 1,096,798 US 1,102,461 US 1,106,241 US 1,111,046 US 1,112,348 US 1,114,833 US 1,119,948 US 1,120,957 US 1,134,435 US 1,135,938 US 12,310,730 US 12,354,193 US 12,484,809 US 12,672,831